Title : Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome.

Pub. Date : 2013 Jan

PMID : 23083540






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. Metformin insulin Sus scrofa
2 OBJECTIVE: The purpose of this study is to evaluate the effect of metformin on insulin signaling in ischemic cardiac tissue in a swine model of metabolic syndrome. Metformin insulin Sus scrofa
3 CONCLUSIONS: Metformin treatment in the context of metabolic syndrome and myocardial ischemia dramatically upregulates the insulin signaling pathway in chronically ischemic myocardium, which is at the crossroads of known metabolic and survival benefits of metformin. Metformin insulin Sus scrofa
4 CONCLUSIONS: Metformin treatment in the context of metabolic syndrome and myocardial ischemia dramatically upregulates the insulin signaling pathway in chronically ischemic myocardium, which is at the crossroads of known metabolic and survival benefits of metformin. Metformin insulin Sus scrofa